Nome Químico: (S,E)-6-(2-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)vinyl)-4-hydroxy-5,6-dihydro-2H-pyran-2-one monosodium salt
Sorrisos: O=C1C=C([O-])C[C@@H](/C=C/C(N2C(C)C)=C(C3=CC=C(F)C=C3)C4=C2C=CC=C4)O1.[Na+]
Inchi: InChI=1S/C16H24N2O4/c17-10-12(7-9-14(18)16(21)22)13(15(19)20)8-6-11-4-2-1-3-5-11/h1-5,12-14H,6-10,17-18H2,(H,19,20)(H,21,22)/t12?,13?,14-/m0/s1
Improvement of development and validation of an RP-HPLC method for the fluvastatin sodium using QbD approach and its application to forced degradation studies
By Balasaheb, Dhamdhere Rupali; Vijayalakshmi, A.
From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2020), 11(4), 6938-6948
Method development and validation of Fluvastatin by RP-HPLC
By Monika, Mallepally; Preethi, Ch. Sai; Aruna Rekha, D.; Pandey, Durgesh; Madhuri, G.
From World Journal of Pharmacy and Pharmaceutical Sciences (2020), 9(5), 1342-1351
Development and Validation of Stability-Indicating HPLC Methods for Quantitative Determination of Pravastatin, Fluvastatin, Atorvastatin, and Rosuvastatin in Pharmaceuticals
By Gomes, Fabio Pereira; Garcia, Pedro Lopez; Alves, Joao Marcel Porto; Singh, Anil Kumar; Kedor-Hackmann, Erika Rosa Maria; Santoro, Maria Ines Rocha Miritello
From Analytical Letters (2009), 42(12), 1784-1804